Cell mediated immunity in healthy women taking oral contraceptives. by Dwyer, J. M. et al.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 91-95 (1975)
Cell Mediated Immunity in Healthy Women Taking
Oral Contraceptives1
JOHN M. DWYER, G. ERIC KNOX, AND RICHARD J. MANGI
Departments ofInternal Medicine and Obstetrics and Gynecology, YaleSchoolof
Medicine, New Haven, Connecticut 06510
Received November27, 1974
Cell-mediated immune function was assessed by both in vitro and in vivo techniques in 20
healthy women on continuous oral contraceptive medication for periods varying from 6 mo to 6
yr. Contrary to previous reports no disturbance ofcell-mediated immunity was detected.
Recent reports" 2 have suggested that oral contraceptive medication can suppress
the lymphocyte response to stimulation in vitro by phytohemagglutination (PHA).
As this test is widely used to assess the competence of the cell-mediated immune
(CMI) system, such reports raise doubts about the integrity of this axis of the im-
mune response in women using estrogen-progestegin combinations. Further, it has
been postulated that the responsible mechanisms may be similar to those depressing
cell-mediated immune function during the third trimester of pregnancy3'4. Factors
which suppress the function of the thymus-derived lymphocyte (T cell) which
mediates CMI are important clinically because the sequelae include a higher inci-
dence of cancer5, and a less adequate response to fungal and viral infection6. In pre-
paring to study CMI in women with chronic vaginal candidiasis (many ofwhom are
taking oral contraceptives) we studied cell-mediated immune responses in 20 ap-
parently healthy women receiving either high- or low-dose estrogen combination
preparations and found no defect in their immunological capacity.
MATERIALS AND METHODS
Patients
Twenty women ranging in age from 18 to 37 yr were studied. All were in good
health and had been taking contraceptives for at least 6 mo (mean 2.8 yr). The prep-
arations used were combinations of progestegin with either 50 Mg, or 80 jg of
estrogen. The responses observed in this group were compared to those of 20 age-
and sex-matched control subjects.
Immunological Methods
All subjects were skin tested for delayed hypersensitivity responses and had blood
drawn for analysis in vitro oflymphocyte function. Intradermal injections of0.1 ml
of the following antigens were used. A 1/100 dilution ofCandida albicans (Hollister-
Stier, Yeadon, PA), mumps skin test antigen, and a 1/10 dilution of tetanus toxoid
fluid USP (Eli Lilly, Indianapolis, IND), and a 1/200 dilution of PHA-P (Difco
Laboratories, Detroit, MI). Reactions to PHA were read at 24 hr, and to the anti-
gens at 48 hr. A response of 10 mm ofinduration was considered positive.
Blood was drawn into heparinized syringes and the lymphocytes so obtained were
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examined for the percentage ofthymus-derived (T) lymphocytes and bone marrow-
derived (B) lymphocytes in the sample7. Lymphocytes were stimulated in tissue cul-
ture for 3 days by the mitogens PHA, concanavalin A (Con-A), and pokeweed
(PWM)7, and for 7 days in Candida albicans and irradiated pooled allogeneic
lymphocytes (mixed lymphocyte reaction -MLR,)8 DNA synthesis, as detected by
the incorporation of tritiated thymidine, was used as a marker of lymphocyte
stimulation. Microcultures utilizing a multiple automated sample harvester were
used throughout. Responses are reported as stimulation indices (cpm from stimu-
lated cells/cpm from cultured but unstimulated cells). Dose-dependent responses
were sought with the mitogens. Thus, to 0.1 ml ofculture media containing cells was
added: 0.1 ml of a 1/500 or 1/10,000 dilution ofPHA-P; 0.1 ml ofconcanavalin A at
a concentration of200 or 20 ,g/ml, and 0.1 ml ofpokeweed at a concentration of 10
or 0.5 gg/ml. All of the above cultures were performed with media containing 20%
pooled human plasma.
Were a humoral suppressant of cell-mediated immune responses present in the
serum of women using contraceptive medication, the thorough washing the above
cells received may mask, in vitro, the in vivo effect of such an agent. Hence, the sera
ofthese subjects were examined for immunosuppressive properties. As we have pre-
viously shown that serum from a large number of healthy control subjects when
added to cultures oflymphocytes from one subject may produce a two-log scatter of
the standard cells response to mitogens and antigens9, we do not believe that immu-
nosuppressive properties ofa given serum can be sought by stimulating normal cells
in one serum and comparing the response to that obtained in another. The test
system used was to stimulate normal cells with PHA and allogeneic pooled ir-
radiated cells in media already containing optimal amounts ofpooled human plasma
with or without an added 10% of the serum to be tested. Thus, the response ofcells
from healthy subjects in a final concentration of 30% plasma (20% pooled human
plasma x 10% pooled human plasma or 20% pooled human plasma x 10% test
sera) were compared using sera from 20 subjects.
RESULTS
The results are presented in Table 1. Comparison ofthe mean value and the stan-
dard errors of the control group and patient group did not reveal a statistically
significant difference for any of the in vitro tests although the mean values for the
PHA and Con A stimulation were lower in the group taking medication when the
smaller dose ofmitogen wasused in the cell cultures, this differenceis not significant
when the data are analyzed by Student's T test. A comparison of skin reactivity
between the control group and contraceptive users did not suggest a diminished ca-
pacity to produce delayed hypersensitivity reactions in the latter group. A com-
parison ofthe results in individual subjects with the mean values and standard devia-
tion of the control group did not identify any individual receiving contraceptive
medication as immunosuppressed.
The sera from the contraceptive users were not immunosuppressive. The results
(Mean Stimulation Index ± S E) follow: Stimulation ofnormal cells with high-dose
PHA in pooled human plasma (30%) 56 ± 3.8; The same cells in pooled human
plasma (20%) + test plasma (10%), 61 4 5.4. With the lower dose of PHA, the in-
dices were 31 ± 4.7 and 33 ± 5.9, respectively. For the mixed lymphocyte reaction
the results were 26 3.5 in pooled plasma alone and 21 i 4.7 in pooled plasma and
plasma from the contraceptive users.
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DISCUSSION
The assessment of cell-mediated immune (CMI) responses in humans remains
difficult and it is being increasingly recognized that no one test is adequate. The ap-
proach taken in this study has been to investigate a number of correlates of CMI
and to utilize dose-dependent stimulation in assaying mitogen stimulation1. This
allows detection of an abnormal responsiveness that may be missed with maximal
stimulation. The problem of looking for a circulating immunosuppressive factor is
also difficult. As has been shown in studies using sera from mice, human sera or
plasma from one subject varies greatly in its ability to support in tissue cultures cells
from another subject9. Thus, iflymphocytes from one control subject are stimulated
by PHA in the presence of50 different samples of sera or plasma from healthy sub-
jects, a wide variation in the response of the cells is noted. It would be easy to
assume that those sera associated with the lowest responses contained an immu-
nosuppressive factor. However, that would imply active suppression when it really
may be lack of some nutritive factor. In any case, as such a result can be obtained
when normal sera are screened it makes it difficult to screen sera from diseased sub-
jects for immunosuppressive factors. Our approach was to supply normal cells with
pooled human plasma in optimal amounts and then add the plasma to be tested. A
resulting decrease in response to stimulation would be more likely to be biologically
significant and to be an active rather than a passive phenomenon. We were inter-
ested in the possible immunosuppressive properties of sera from women on oral
contraceptives as a number of reports suggest that in pregnancy there is a circu-
lating plasma factor than can suppess CMI. No such factor was found in the plasma
ofour subjects. Thus, despite the problems inherent in tests whose normal values in-
clude wide standard deviations, it seems clear that the commonly used oral
contraceptives which feature combinations ofestrogen and progestegin do not effect
CMI. It is thus unlikely that the changes in immunological function seen in preg-
nancy are related to the development of a hormonal balance similar to that induced
by oral contraceptives. Previous reports suggesting that oral contraceptives affect
cell-mediated immunity have been limited in the number ofpatients studied and the
breadth oftheir assessment ofCMI, and insufficient information was provided to es-
tablish the similarity of the populations variously studied. Impaired CMI may
predispose to cancer formation but there have been no suggestions of an increased
incidence ofcervical cancer among oral contraceptive users", and a lower incidence
of breast cancer12 has been reported. These facts, which suggest indirectly that im-
munological surveillance for Cancer is not diminished by oral contraceptive prep-
arations, are supported by the current direct evaluation of the CMI system in
contraceptive users.
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